NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...

GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to ...

The Virtual Investor "What This Means” segment featuring HCW Biologics is now available here.

NanoViricides (NNVC) announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in cell culture studies as ...

Nanomedicine uses ultra-small particles to deliver drugs directly to the tissues and cells that need them, improving ...

Fractyl Health Inc. (NASDAQ:GUTS) is one of the best young stocks with huge upside potential. On October 7, Fractyl Health ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today ...

The fight against cancer is reaching a promising new milestone with the development of modified immune cells capable of ...

Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...

Keytruda plus Lenvima demonstrates durable 5-year survival benefit versus chemotherapy for patients with advanced endometrial carcinoma following one prior platinum-based regimen: ...

In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...

FDA discussions around accelerated approval pathways now enable pooling clinical data to expedite biologics licenses for gene therapies, signaling regulatory momentum that favors early entrants ...